| Novel Strategy for Early Detection of Esophageal Squamous Cell Carcinoma |
Chromoendoscopy, EsoCAN assay, EsophaCap Sponge |
Recruiting |
| Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV |
9 valent human papillomavirus vaccine (Types 6, 11, 16, 18, 31, 33, 45, 52, 58), Saline Placebo |
Active, not recruiting |
| Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients with Stage I-III Breast Cancer |
Nilotinib, Nilotinib Hydrochloride Monohydrate, Paclitaxel, Placebo, Questionnaire Administration |
Active, not recruiting |
| New Assessment System in Measuring Symptom Distress in Cancer Patients |
Interview, Quality-of-Life Assessment, Questionnaire Administration |
Recruiting |
| Neuropsychological and Behavioral Testing in Younger Patients With Cancer |
Cognitive Assessment, Quality-of-Life Assessment |
Active, not recruiting |
| NCI COVID-19 in Cancer Patients, NCCAPS Study |
Biospecimen Collection, Data Collection, Quality-of-Life Assessment, Questionnaire Administration |
Active, not recruiting |
| National Liver Cancer Screening Trial |
GALAD, Liver Ultrasound with or without AFP |
Recruiting |
| National Cancer Institute "Cancer Moonshot Biobank" |
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Medical Chart Review, Paracentesis, Positron Emission Tomography |
Recruiting |
| Nashville Early Diagnosis Lung Cancer Project |
Blood sample collection, Bronchoalveolar lavage, Bronchoscopy, Buccal epithelium collection, Computerized tomography (CT) scan of the chest, Nasal brushings, Pulmonary function tests, Questionnaire-data collection, Sputum sample, Urine sample |
Active, not recruiting |
| Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer |
Naloxegol, Placebo, Laboratory Biomarker Analysis, Quality-of-Life Assessment |
Active, not recruiting |
